|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.20 EUR | -0.76% |
|
-1.50% | -5.76% |
| 05-29 | HAEMATO AG announces Annual dividend, payable on July 10, 2026 | CI |
| 01-31 | PHOENIX Pharmahandel SE completed the acquisition of HAEMATO Pharm GmbH from HAEMATO AG. | CI |
| Market Cap | 66.91M 76.55M 61.88M 56.78M 107M 7.38B 109M 738M 290M 3.6B 287M 281M 12.44B | P/E 2023 * |
-
| P/E 2024 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 66.91M 76.55M 61.88M 56.78M 107M 7.38B 109M 738M 290M 3.6B 287M 281M 12.44B | EV / Sales 2023 * |
-
| EV / Sales 2024 * | - |
| Free-Float |
99.67% | Yield 2023 * |
-
| Yield 2024 * | - |
| 1 day | -0.76% |
| Manager | Title | Age | Since |
|---|---|---|---|
Patrick Brenske
CEO | Chief Executive Officer | - | 30/11/2020 |
Attila Strauss
PRN | Corporate Officer/Principal | - | 01/04/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrea Grosse
CHM | Chairman | 61 | 30/05/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.76% | -1.50% | - | - | 76.53M | |
| +3.44% | +2.32% | +55.25% | +21.22% | 305B | |
| -1.53% | -1.18% | +24.90% | -7.29% | 69.67B | |
| +1.21% | -2.07% | +32.72% | +91.18% | 8.99B | |
| +0.23% | -1.27% | +6.72% | -0.25% | 8.52B | |
| -3.05% | +4.98% | +10.85% | +28.13% | 4.17B | |
| +1.53% | -3.29% | -19.72% | +3.79% | 4.11B | |
| +1.87% | +2.46% | -37.23% | +24.94% | 3.48B | |
| +0.26% | -1.79% | +42.83% | +62.67% | 2.77B | |
| -0.81% | +8.11% | +14.84% | -16.29% | 2.28B | |
| Average | +0.25% | -1.83% | +14.57% | +23.12% | 45.48B | |
| Weighted average by Cap. | +2.32% | -4.79% | +46.27% | +17.45% |
| 2023 * | 2024 * | |
|---|---|---|
| Net sales | - | - |
| Net income | - | - |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- HAEK Stock
- HAE Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
